Tempest Therapeutics raises ~$4.6M gross in registered direct offering of stock and prefunded warrants

Tempest Therapeutics, Inc.

Issued 405,000 shares at $6.25 each and prefunded warrants for 334,000 shares at $6.249 each.
Net proceeds estimated at ~$4.1M after placement agent fees and expenses.
Proceeds to support strategic alternative process and working capital; cash runway into Q2 2026.
Placement agent H.C. Wainwright receives 6.0% cash fee on gross proceeds.
Prefunded warrants exercisable at $0.001 per share, with 4.99% beneficial ownership limitation (holder may elect up to 9.99%).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.